Amneal Launches Brekiya® for Migraine and Cluster Headaches
Amneal Pharmaceuticals has proudly introduced Brekiya®, a groundbreaking autoinjector that provides an easy-to-use alternative for adults dealing with migraine headaches, whether with or without aura, as well as cluster headaches. This innovative treatment is now available exclusively through select specialty pharmacies, ensuring that patients have access to this much-needed solution.
What Makes Brekiya® Unique?
Brekiya® (dihydroergotamine mesylate injection) marks a significant advancement in headache treatment. Approved as the first ready-to-use dihydroergotamine autoinjector in the U.S., it serves to swiftly alleviate symptoms associated with acute migraine and cluster headaches. Healthcare professionals are expressing excitement about what this means for patient care—often, individuals suffering from these debilitating conditions previously had limited options for effective relief.
Accessible Treatment for Millions
Migraine is a persistent problem for nearly 43 million Americans, while approximately 300,000 individuals experience cluster headaches. Given these staggering numbers, Brekiya® provides a valuable alternative for those seeking effective treatment options, especially since headaches are among the leading reasons for emergency room visits in the U.S.
Understanding the Benefits of Brekiya®
Brekiya® offers multiple advantages over traditional treatment methods. Patients can self-administer the injection, which promotes timely and effective relief at home without the need for emergency care. The convenience of self-administration can ultimately improve the quality of life for those who regularly experience severe headaches. Joe Renda, Senior Vice President of Amneal, emphasized the company's commitment to enhancing access and education for healthcare providers regarding this new product.
Cost and Accessibility for Patients
For eligible commercially insured patients, there is a benefit to using Brekiya®; they may find their out-of-pocket costs reduced significantly, with prices starting as low as $40 per carton of four autoinjectors. This affordability is crucial, as it lowers barriers to access and allows for broader patient uptake.
Your Safety Matters: Important Information
While Brekiya® presents a promising treatment avenue, patients should be aware of essential safety information. It should not be used in conjunction with strong CYP3A4 inhibitors, such as certain antibiotics and protease inhibitors, due to serious potential risks, including peripheral ischemia. Individuals with specific medical conditions or those taking particular medications should consult their healthcare providers to ensure Brekiya® is a safe choice for their treatment.
How to Use Brekiya® Effectively
Brekiya® is administered subcutaneously and comes in single-dose autoinjectors. It is essential for patients to follow their healthcare provider's instructions closely. If symptoms persist after the first dose, patients may administer additional doses as needed while adhering to recommended guidelines regarding spacing and maximum doses.
Possible Side Effects You Should Know
As with any medication, potential side effects exist. While Brekiya® can effectively relieve headache pain, it may also cause serious complications such as heart issues, strokes, and even increased blood pressure. Patients are advised to monitor their reactions and communicate any adverse effects to their healthcare providers promptly. Your health is paramount, and staying informed about all possible side effects helps ensure safety.
About Amneal Pharmaceuticals
Founded on innovation and commitment, Amneal Pharmaceuticals (NASDAQ: AMRX) is dedicated to developing and distributing a diverse range of over 280 pharmaceutical products. Their mission is to make healthy living possible by delivering advanced medical solutions across various therapeutic areas, including those targeting central nervous system disorders. Amneal continues to push the boundaries of accessible healthcare and empower patients around the globe.
Frequently Asked Questions
What is Brekiya® used for?
Brekiya® is prescribed for the acute treatment of migraine headaches, with or without aura, and for acute cluster headaches in adults.
Is Brekiya® safe for children?
Brekiya® has not been proven safe or effective in children, and its use is recommended only for adults.
How do I inject Brekiya®?
Brekiya® is intended for subcutaneous injection. Always follow your healthcare provider’s instructions regarding administration.
What should I do if I experience side effects?
If you notice any side effects, especially severe ones, contact your healthcare provider immediately.
Where can I get Brekiya®?
Brekiya® is available exclusively through certain specialty pharmacies such as Walgreens and Sterling Specialty Pharmacy.
